ISSN: 0049-3848
Journal Home
Journal Guideline
Thrombosis Research Q1 Unclaimed
Thrombosis Research is a journal indexed in SJR in Hematology with an H index of 118. It has an SJR impact factor of 1.678 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1.678.
Thrombosis Research focuses its scope in these topics and keywords: venous, factor, patients, thromboembolism, von, disease, heparin, treatment, randomized, platelet, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -


- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
1.678
SJR Impact factor118
H Index361
Total Docs (Last Year)1149
Total Docs (3 years)10387
Total Refs6791
Total Cites (3 years)834
Citable Docs (3 years)7.23
Cites/Doc (2 years)28.77
Ref/DocOther journals with similar parameters
Annals of Oncology Q1
CA - A Cancer Journal for Clinicians Q1
Blood Q1
Leukemia Q1
Journal of Thrombosis and Haemostasis Q1
Compare this journals
Aims and Scope
Best articles by citations
Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site
View morePOTENTIAL USEFULNESS OF ANTIPLATELET AGENTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
View moreA New System to Detect Native Microaggregates of Platelets In Vivo, with a Novel Platelet Aggregometer Employing Laser Light Scattering
View moreThe treatment of severe or recurrent deep venous thrombosis
View moreSTUDIES OF THE t-PA-CATALYZED GLU-PLASMINOGEN ACTIVATION ON DIFFERENT MODELS OF POLYMERIC FIBRIN
View moreFibrinogenemia Tampere - A dysfibrinogenemia with defective gelation and thromboembolic disease
View moreHUMAN PLACENTAL TISSUE FACTOR: PROTEASE SUSCEPTIBILITY OF EXTRACELLULAR AND CYTOPLASMIC DOMAINS
View moreLDL-Apheresis Removes Serum Amyloid P and A in Hypercholesterolemic Patients
View moreIN VITRO EFFECTS OF INOGATRAN, A SELECTIVE LOW MOLECULAR WEIGHT THROMBIN INHIBITOR
View moreA partial factor V deficiency in anticoagulated lyophilized plasmas has been identified as a cause of the international normalized ratio discrepancy in the external quality assessment scheme
View moreSuccessful heparin desensitization after heparin-induced anaphylactic shock
View moreActivated coagulation/fibrinolysis system and platelet function in acute thrombotic stroke patients with increased C-reactive protein levels
View moreDecreased fibrinolytic stimulation by a short-term venous occlusion test in patients with cerebrovascular disease
View moreHyperlipidemia: A novel etiologic factor in deep vein thrombosis
View moreModerate Hyperhomocyst(e)inemia Is Associated with the Presence of Coronary Artery Disease and the Severity of Coronary Atherosclerosis in Koreans
View morePerformance characteristics and clinical evaluation of an in vitro bleeding time device - Thrombostat 4000
View moreComparision of the efficacy of D-dimer, fibrin degradation products and prothrombin fragment 1+2 in clinically suspected deep venous thrombosis
View moreSULFATED POLYSACCHARIDE FROM THE LEAVES OF ARTEMISIA PRINCEPS ACTIVATES HEPARIN COFACTOR II INDEPENDENTLY OF THE LYS173 and ARG189 RESIDUES OF HEPARIN COFACTOR II
View moreEffects of hemodialysis and longterm erythropoietin treatment on protein C, and on free and total protein S
View moreEffect of Iron Therapy on the Whole Blood Platelet Aggregation in Infants with Iron Deficiency Anemia*
View moreProthrombin Complex Concentrates
View moreAntiaggregating and vasodilatory effects of a new nitroderivative of acetylsalicylic acid
View moreInhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion
View moreDevelopmental expression of protein C and protein S in the rat
View more
Comments